Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 5,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Director acquired 5,000 shares (grant or award)
  5. 4 Grant or award Director acquired 5,000 shares (grant or award)
  6. 4 Grant or award Director acquired 5,000 shares (grant or award)
  7. 4 Grant or award Chief Scientific Officer acquired 5,000 shares (grant or award)
  8. 4/A Open-market buy Chief Scientific Officer bought 12,000 shares at $10.00 ($120,000)
  9. 4 Open-market buy Director bought 100 shares at $8.05 ($805)
  10. 4 Open-market buy Director bought 100,000 shares at $10.00 ($1,000,000)
  11. 4 Returned to the company Director returned 5,000 shares (to the company)
  12. 4 Grant or award Director acquired 5,000 shares (grant or award)
  13. 4 Grant or award Director acquired 5,000 shares (grant or award)
  14. 4 Grant or award Director acquired 5,000 shares (grant or award)
  15. 4 Open-market buy Chief Scientific Officer bought 103,000 shares at an average $9.98 ($1,028,230)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 12 of 13 · 246 filings